IDSA and HIVMA Call for Sustained, Evidence-based Responses to the Link Between Infectious Diseases and Opioid Use Disorders
The national opioid crisis is fueling a rise in infectious diseases including HIV, viral hepatitis and bacterial infections such as infective endocarditis and musculoskeletal infections. Such secondary consequences of opioid addiction constitute an additional public health threat that demands urgent, coordinated, evidence-based and sustained action. IDSA and HIVMA appreciate the concentration of congressional and federal agencies on these issues. Most recently, we were encouraged by this week's
IDSA and HIVMA members call on both the
In the
ID and HIV clinicians on the frontlines of the opioid epidemic report that 25 to 50 percent of their inpatient consultations are due to infections among patients who inject drugs. The ability to treat these infections and prevent future infections is severely compromised by the limited access to addiction treatment within the hospital setting. Without access to effective programs for co-treating both addiction and infectious diseases, patients frequently return with even more serious infections or increasingly drug-resistant infections.
Effective responses to this public health crisis must recognize addiction as a medical condition that requires a long-term comprehensive approach to prevention and treatment. Any investment will require new resources so as not to compromise other public health responses that are already challenged by inadequate funding and competing demands. The
More on IDSA and HIVMA recommendations on addressing infectious diseases and opioid use disorder is on the IDSA and HIVMA websitesThe
AHIP Responds to Omnibus Spending Bill
Congress Comes to Its Senses for a Moment, Rejects Trump’s Dangerous Budget Proposal
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News